Quality of life after liver resection for hepatobiliary malignancies

British Journal of Surgery

Volumn 95, Issue 7, 2008, Pages 845-854

  Dasgupta, D ^a   Smith, A B ^a   Hamilton Burke, W ^a   Prasad, K R ^a   Toogood, G J ^a   Velikova, G ^a   Lodge, J P A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATOBILIARY SYSTEM TUMOR; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; ADJUVANT CHEMOTHERAPY; BILIARY TRACT TUMOR; LIVER TUMOR; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PSYCHOLOGICAL ASPECT; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 47249162345     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6180     Document Type: Article

References (26)

1. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 2006; 94: 982-999.
2. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-1314.
3. Perry JF, Poustchi H, George J, Farrell GC, McCaughan GW, Strasser SI. Current approaches to the diagnosis and management of hepatocellular carcinoma. Clin Exp Med 2005; 5: 1-13.
4. Cella DF, Cherin EA. Quality of life during and after cancer treatment. Compr Ther 1988; 14: 69-75.
5. Velikova G, Stark D, Selby P. Quality of life instruments in oncology. Eur J Cancer 1999; 35: 1571-1580.
6. Bottomley A, Aaronson NK. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience. J Clin Oncol 2007; 25: 5082-5086.
7. Lipscomb J, Reeve BB, Clauser SB, Abrams JS, Bruner DW, Burke LB et al. Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol 2007; 25: 5133-5140.
8. Eid S, Stromberg AJ, Ames S, Ellis S, McMasters KM, Martin RC. Assessment of symptom experience in patients undergoing hepatic resection or ablation. Cancer 2006; 107: 2715-2722.
9. Poon RT, Fan ST, Yu WC, Lam BK, Chan FY, Wong J. A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg 2001; 136: 693-699.
10. Krabbe PF, Peerenboom L, Langenhoff BS, Ruers TJ. Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30. Qual Life Res 2004; 13: 1247-1253.
11. Ueno S, Tanabe G, Nuruki K, Yoshidome S, Kubo F, Kihara K et al. Quality of life after hepatectomy in patients with hepatocellular carcinoma: implication of change in hepatic protein synthesis. Hepatogastroenterology 2002; 49: 492-496.
12. Tanabe G, Ueno S, Maemura M, Kihara K, Aoki D, Yoshidome S et al. Favorable quality of life after repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 2001; 48: 506-510.
13. Kuchler T, Henne-Bruns D, Rappat S, Graul J, Hoist K, Williams JI et al. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 1999; 46: 322-335.
14. Langenhoff BS, Krabbe PF, Peerenboom L, Wobbes T, Ruers TJ. Quality of life after surgical treatment of colorectal liver metastases. Br J Surg 2006; 93: 1007-1014.
15. Ruers TJ, Joosten JJ, Wiering B, Langenhoff BS, Dekker HM, Wobbes T et al. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study. Ann Surg Oncol 2007; 14: 1161-1169.
16. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
17. Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16: 139-144.
18. Sprangers MA, Schwartz CE. The challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol 1999; 10: 747-749.
19. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-1260.
20. Earlam S, Glover C, Davies M, Fordy C, Allen-Mersh TG. Effect of regional and systemic fhuorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients. J Clim Oncol 1997; 15: 2022-2029.
21. Chow PK, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: a multicenter randomized controlled trial. Hepatology 2002; 36: 1221-1226.
22. Pistevou-Gombaki K, Eleftheriadis N, Plataniotis GA, Sofroniadis I, Kouloulias VE. Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the EORTC QLQ-C30 questionnaire. Palliat Med 2003; 17: 257-262.
23. Steel J, Baum A, Carr B. Quality of life in patients diagnosed with primary hepatocellular carcinoma: hepatic arterial infusion of Cisplatin verrus 90-Yttrium microspheres (Therasphere). Psycbooncology 2004; 13: 73-79.
24. Maughan TS, James RD, Kerr DJ, Ledermann JA, Seymour MT, Topham C et al. Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial. Lancet 2003; 361: 457-464.
25. Earlam S, Glover C, Fordy C, Burke D, Allen-Mersh TG. Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases. J Clin Oncol 1996; 14: 171-175.
26. Kavadas V, Blazeby JM, Conroy T, Sezer O, Holzner B, Koller M et al. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer 2003; 39: 1259-1263.